Haiti vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 15-59
Haiti
52.3%
in 2021
Kyrgyzstan
52.4%
in 2021
Haiti rank
98th
Kyrgyzstan rank
97th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Haiti
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 52.4% against 52.3% in Haiti, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kyrgyzstan ahead.
Haiti ranks 98th and Kyrgyzstan ranks 97th of 185 countries.
Across the 3 decades both report, Haiti averaged higher in 1 and Kyrgyzstan in 2.
Head to head by decade
| Decade | Haiti | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.4% | 64.9% | 21.5% | Kyrgyzstan |
| 2010s | 42.8% | 72.3% | 29.5% | Kyrgyzstan |
| 2020s | 55.4% | 54.5% | 0.9% | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Haiti or Kyrgyzstan?
- Kyrgyzstan, at 52.4% against 52.3% in Haiti as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Haiti and Kyrgyzstan?
- 0.1%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Haiti and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Haiti and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Haiti ranks 98th and Kyrgyzstan ranks 97th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.